134 results
Page 3 of 7
8-K
EX-99.1
f0aitry0clm
28 Jun 21
Other Events
6:07am
8-K
m8cun94 lamb3
28 Jun 21
Other Events
6:07am
8-K
EX-99.2
wse135g68emv
27 May 21
GSK and Vir Biotechnology Announce Sotrovimab (VIR-7831) Receives
4:55pm
8-K
EX-99.1
88t q5k17
27 May 21
GSK and Vir Biotechnology Announce Sotrovimab (VIR-7831) Receives
4:55pm
8-K
7dytzm
27 May 21
GSK and Vir Biotechnology Announce Sotrovimab (VIR-7831) Receives
4:55pm
8-K
d5of32vog7 54k
24 May 21
Entry into a Material Definitive Agreement
5:00pm
8-K
EX-99.1
07a3oyogejj
21 May 21
CORRECTION — EMA Issues Positive Scientific Opinion on GSK and Vir Biotechnology’s
3:38pm
8-K
EX-99.1
7jrpm o4vba0vyw
6 May 21
Vir Biotechnology Provides Corporate Update and Reports First Quarter 2021 Financial Results
4:24pm
8-K
EX-99.1
9ztg46 o2
13 Apr 21
Other Events
4:06pm
8-K
EX-99.1
9lhjzjwk4g p03
25 Feb 21
Vir Biotechnology Provides Corporate Update and Reports Fourth Quarter and Full Year 2020 Financial Results
4:15pm
8-K
EX-99.1
mh8qbg7dy9ndxbq8
19 Feb 21
GSK and Vir Biotechnology Expand Coronavirus Collaboration to Advance New Therapeutics for Influenza and Other Respiratory Viruses
5:03pm
8-K
80p8s
19 Feb 21
GSK and Vir Biotechnology Expand Coronavirus Collaboration to Advance New Therapeutics for Influenza and Other Respiratory Viruses
5:03pm
8-K
EX-99.1
8ko5h22i
28 Jan 21
Other Events
4:05pm
8-K
EX-99.2
x0qij3s57i
28 Jan 21
Other Events
4:05pm
S-3ASR
EX-1.2
i3j hsxez99u11r
10 Nov 20
Automatic shelf registration
5:13pm